Autoantibodies are antibodies that lose the ability to tell “self” from “nonself” and begin attacking the body’s own cells, proteins, and other biological components.
Healthy people may carry some autoantibodies without developing autoimmunity. Genetics and environmental or other triggers may increase susceptibility to autoimmune disorders.
Testing for autoantibodies may help predict onset of autoimmune disease, as well as diagnose and guide treatment for existing disease. Immunosuppression may slow production of autoantibodies but doesn’t eliminate them.
Antibodies are critical for protecting us from disease-causing bacteria and viruses, but antibodies that target our own bodies can lead to autoimmune disease. In this comprehensive guide, we’ll discuss what autoantibodies are, as well as some common types of autoantibodies and autoimmune diseases.
Antibodies, or immunoglobulins, are Y-shaped proteins produced by white blood cells known as B lymphocytes, or B cells. Antibodies make up about 20% of the total protein content of plasma, the part of blood that is left after red and white blood cells and platelets are removed. (Source)
Antibodies find pathogens and other foreign substances that have entered the body, stick to them, and signal other members of the immune system to come help eliminate them.
Antibodies recognize foreign invaders by molecules the foreigners carry called antigens. Each antibody fits a specific antigen, and the introduction of a new antigen causes B cells to produce new antibodies to match it. This is called the adaptive, or acquired, immune response — the immune system adapts to new challenges.
Where in the body antibodies do their work is determined by their isotype. (Source)
Antibodies are formed of strings of smaller proteins known as chains. Light chains are each made up of about 220 amino acids, and heavy chains are each made up of about 440 amino acids. The structure of the heavy chains determine what isotype, or class, of immunoglobulin an antibody is. (Source)
Human antibody heavy chains have five isotypes:
The role of antibodies is to protect the body from pathogens and other substances that enter the body from the outside. For antibodies to work properly, the immune system must be able to distinguish between “self” and “nonself” — that is, to tell the difference between foreign invaders and the cells, proteins, and other substances that belong in the body.
Antibodies that lose this ability and mistakenly target the body’s own tissues are called autoantibodies. Autoantibodies may bind with antigens on many different substances in the body, including nucleic acids, lipids, and proteins. These antigens may be found on the surface of cells, inside cells, or in the fluid between cells. In the most common systemic autoimmune diseases, autoantibodies target molecules inside the cell. (Source)
The B cells that produce antibodies start out in the blood marrow and mature in the spleen, a small organ tucked up under the stomach. B cells that might react to the body’s own tissues generally don’t make it into circulation, but some do slip through. For this reason, it isn’t unusual for healthy people to have some “natural” autoantibodies in their blood. (Source)
It is thought that natural autoantibodies are present from birth. The B cells that produce them also have a role in producing harmful pathogenic autoantibodies. They have an affinity for self-antigens — antigens found on cellular components produced in the body. (Source)
Autoantibodies are antibodies that attack the body’s own cells, proteins, and tissues. They may be present in the body even if a person does not have an autoimmune disease. Autoantibodies can cause autoimmune disease in susceptible individuals, and they can be a sign that an individual is genetically predisposed to an autoimmune disease.
Autoimmune disease is a general term used to describe any condition in which the immune system attacks and destroys healthy cells in the body by mistake. This can affect any tissue or organ in the body, including the skin, joints, blood vessels, muscles, and the nervous system.
Although there are over 80 different types of autoimmune diseases, the most common include inflammatory bowel disease (IBD), type 1 diabetes, and rheumatoid arthritis. (Source)
Many autoimmune diseases associated with autoantibodies in the blood are long-term and chronic. There may be a relationship between the amount of autoantibodies detected in the blood and the severity of the autoimmune disease. In some autoimmune diseases, such as type 1 diabetes and thyroiditis, autoantibodies may be detected years before any symptoms appear. (Source)
Autoantibodies can be used as markers of autoimmune disease activity. In diseases with a long onset, such as type 1 diabetes and thyroiditis, autoantibodies may be detected before symptoms become noticeable. Early testing for autoantibodies can help predict whether and when symptoms are likely to occur.
Autoantibodies can also be used to determine whether or not a condition is due to an autoimmune disorder, helping guide treatment and management of symptoms.
Lastly, the presence of autoantibodies may help predict future onset of autoimmune disease, providing an opportunity to forestall disease through preventive therapy and avoidance of environmental triggers. (Source)
Because autoantibodies are sometimes detected before symptoms begin, they may be useful for predicting disease onet. Whether autoantibody tests can be used in this way depends on their sensitivity, specificity, and positive predictive value. (Source)
This is calculated by dividing the number of people with a particular autoantibody who develop an associated disease by the total number of people who develop the disease. If every person who develops a specific autoimmune disease has that autoantibody, this indicates a high disease sensitivity. A panel of different autoantibodies may increase the sensitivity of prediction.
This is the chance that a person without that autoantibody marker will remain disease-free. This is calculated by dividing the number of people without the autoantibody who do not develop the disease by the total number of people who do not develop the disease.
There is a reciprocal relationship between sensitivity and specificity: as sensitivity increases, specificity decreases. The higher the threshold needed for autoantibody positivity, the more specific the test identifies the patients with the disease. However, this comes at the expense of excluding the patients with lower autoantibody counts and thus decreases the sensitivity.
This is calculated by dividing the number of people who tested positive through the autoantibody testing and who develop clinical disease by the overall number of people who tested positive through the autoantibody testing. A high positive predictive value indicates that more people with the autoantibody but without the clinical disease will eventually develop the disease.
Because healthy people may have some circulating autoantibodies, the presence of autoantibodies in itself doesn’t ensure a diagnosis of autoimmune disease. Often, multiple laboratory tests combined with evaluation of signs and symptoms are needed in order to diagnose an autoimmune disease. Components of a laboratory exam may include a blood count with a metabolic panel for different blood components, inflammatory markers, and autoantibodies. (Source)
Autoantibody testing is usually done using the enzyme-linked immunosorbent assay (ELISA) method. With ELISA, laboratory plates coated with specific antigens are exposed to the patient’s serum (the liquid part of the blood left when red blood cells and platelets are removed). If antibodies to the antigens are present, they will bind with the antigens. (Source)
Research into autoantibodies and their relation to autoimmune disease is ongoing, but the following are some of the most common and best-understood autoantibodies.
Most autoantibodies bind to the surface of cells, but antinuclear antibodies (ANAs) bind to components of a cell’s nucleus, or to other substances inside the cell. Antinuclear antibodies are associated with a number of autoimmune diseases but may also be detected in healthy people. Testing for them is helpful in ruling a diagnosis in or out, but they can’t be used by themselves to confirm a diagnosis. (Source)
A subset of ANAs are known as extractable nuclear antigen antibodies (ENAs), which react with specific proteins in the cell nucleus. A positive ANA result may be followed by testing for ENAs to help narrow down an autoimmune disease diagnosis. (Source)
Anti-Smith antibodies are specific for systemic lupus erythematosus (SLE) and important for its classification. The level of antibodies present in blood serum are correlated with disease activity of SLE. Thus, these antibodies are clinically important as a marker for disease activity and associated disease flares. (Source)
Anti-RNP antibodies may be detected in the presence of several connective tissue diseases, and high levels of anti-RNP antibodies are associated with a diagnosis of mixed connective tissue disease (MCTD). (Source)
Autoantibodies to the antigens Ro (SS-A) and La (SS-B) are associated especially with Sjögren’s syndrome and SLE, but may be present in many other autoimmune diseases. In pregnant women, these antibodies indicate an increased risk of neonatal lupus syndrome, which is severe and is associated with congenital heart block. (Source, Source, Source)
Anticardiolipin antibody (ACA) targets platelets and cell membranes made up of phospholipids. It is implicated in SLE, rheumatoid arthritis, and a condition called antiphospholipid syndrome (APS), which leads to blood clots and increased risk of premature birth and fetal loss. (Source)
The antibodies known as rheumatoid factors are sometimes found in healthy people, and it’s believed they have a protective function. In some cases, though, it is believed they may mutate into pathogenic forms that can cause not just rheumatoid arthritis, but other autoimmune and non-autoimmune diseases as well. (Source)
Thyroid disorders such as Hashimoto’s thyroiditis, which causes hypothyroidism, and Graves’ disease, which causes hyperthyroidism, are autoimmune diseases. They are associated with antibodies to an enzyme called thyroid peroxidase (TPO) and to a protein called thyroglobulin (Tg). (Source)
Destruction of insulin-producing cells in the pancreas leads to type 1 diabetes. Antibodies that bind to the autoantigens glutamic acid decarboxylase, IA-2, and insulin have been identified. Studies show that the presence of two or more of these autoantibodies makes development of type 1 diabetes more likely than does presence of a single autoantibody. (Source, Source)
Celiac disease is associated with antibodies to gliadin, a component of gluten, and to connective tissue in the GI tract. Currently, avoiding gluten in the diet is the treatment of choice for celiac disease. (Source)
Adrenalitis is an autoimmune disease that affects the adrenal glands, which are located on top of the kidneys and produce hormones that are critical to life. Destruction of the adrenal glands leads to a condition of adrenal insufficiency known as Addison’s disease. The development of adrenal failure is more likely when the antibodies are present in childhood. (Source)
Rather than targeting specific autoantibodies, treatments often focus on immunosuppression, or limiting immune reactions in general. Some drugs, for example, slow down replication of the B cells that produce antibodies. Immunosuppression increases susceptibility to infection and so carries its own risks. (Source)
Even healthy people may have some circulating autoantibodies, but genetic predisposition or environmental or other triggers may lead to autoimmune disorders. There is currently no cure for autoimmune disease, but it may be possible to suppress production of some autoantibodies. Testing for autoantibodies may help predict the onset of autoimmune disease, diagnose and monitor progression, and help guide treatment.